Fatty acids in the blood may predict risk of developing schizophrenia from cannabis use

FHS
March 21, 2025
11:12 pm

The UPV/EHU study, recently published in the journal Scientific Reports, has analyzed and compared the fatty acids in the blood of individuals with schizophrenia, of those with cannabis use disorder and of those with both diagnoses, with the aim of shedding light on new biomarkers and improving the understanding of the biological relationship between the two disorders.

Gerresheimer decisively continues on profitable growth course in financial year 2023 – Biotech Investments

EQS-News: Gerresheimer AG / Key word(s): Annual Results Gerresheimer decisively continues on profitable growth course in financial year 2023 22.02.2024 / 07:00 CET/CEST The issuer

February 23, 2024

Outgoing CDC director girds against an overhaul, and tries to calm staff nerves

As her tenure as director of the Centers for Disease Control and Prevention winds down, Mandy Cohen is in persuasion mode — simultaneously trying to

December 16, 2024

Why Andreessen Horowitz’s Julie Yoo sees AI as a ‘leapfrog opportunity’ for healthcare

The Silicon Valley venture firm Andreessen Horowitz in recent years has been investing heavily in healthcare and biotech, guided by its well-known mantra that “software

October 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.